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approach and was evaluated by an observer blinded to the MSCT
results.
Results: The diagnostic accuracy of MSCT for the detection or exclu-
sion of signiﬁcant stenosis in grafts body and their anastomotic sites
was 99.28%, sensitivity, speciﬁcity, positive and negative predictive
values were 97.75%, 100%, 100%, 98.95%. The diagnostic accuracy
for detection of degree of graft stenosis (mild, moderate, severe or
occluded) was 97.18%.
Conclusion: Noninvasive MSCT angiography is an excellent tool for
evaluating patency or degree of stenosis of bypass grafts body and
their anastomotic sites in post-CABG patients.
http://dx.doi.org/10.1016/j.ehj.2013.12.019
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Diﬀerentiation between atrioventricular reentrant tachycardia
(AVRT) and AV nodal reentrant tachycardia (AVNRT) can be some-
times challenging in the EP lab. RV pacing during SVT produces pro-
gressive QRS fusion before QRS morphology becomes stable. This
fusion zone (FZ) may diﬀerentiate AVRT from AVNRT independent
of entrainment success. PPI-TCL during RV entrainment can help in
diﬀerentiation; however it has some fallacies and limitations. We
thought to compare the accuracy of atrial preexcitation (AP) & Stim-
ulus to atrial (S-A) interval ﬁxation in relation to fusion zone in iden-
tifying the mechanism of SVT.
We studied retrospectively and prospectively the eﬀect of properly
timed RVP on atrial timing during FZ. 118 SVT patients had RVP
within 40 ms shorter than tachycardia cycle length (TCL). S–A interval
and atrial CL were measured during FZ and with each QRS complex
thereafter. A ﬁxed S–A interval was deﬁned as variation <5 ms during
RVP & AP is the ﬁrst change in atrial CLP 10 ms.
9 patients were excluded due to cycle length oscillation > 10 ms
before the onset of RVP and 6 patients had atrial tachycardia (VA dis-
sociation with RVP) and were excluded. In the remaining 103 patients,
PPI-TCL was signiﬁcantly longer in AVNRT patients but postpacing
response couldn’t be assessed in 12 patients who showed consistent ter-
mination of tachycardia during RVP entrainments; 3 AVNRT patients
(5%) & 9 AVRT patients (22%). And when assessed it was not diag-
nostic in additional 4 (6%) patients with AVNRT (<115 ms) & 7
(17%) patients with ORT (P115 ms). Atrial pre-excitation (AP)
occurred during FZ in most AVRT patients and after FZ in most
AVNRT patients. However, S-A ﬁxation occurred during FZ in all
AVRT patients and after FZ in all AVNRT patients. Fixation of S-
A interval in relation to FZ was more accurate than either AP or
PPI-TCL in identifying the mechanism of SVT (100%, 92.4% and
84.8% consecutively).
We can conclude that during RVP within 40 ms of the tachycardia
cycle length, ﬁxed S–A interval and AP in relation to FZ were superior
to PPI-TCL measurement in identifying the mechanism of SVT.
http://dx.doi.org/10.1016/j.ehj.2013.12.020
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Background: Diabetes has been shown to be independent predictor of
restenosis after percutaneous coronary intervention (PCI). Diabetes
mellitus has been proved to be a strong risk factor for in-stent resteno-
sis. Restenosis after stent implantation remains the “Achilles’heel” of
PCI, and patients with diabetes still have poorer clinical outcomes
compared to non-diabetics.1
Objective: (Aim of work) The aim of the present study is to evaluate
whether the level of HbA1c as an indicator for the glycaemic control
in diabetic patient is related to major cardiovascular events during
the follow up in diabetic patients after percutaneous coronary inter-
vention [(PCI) – stenting].
Methods: This study included 60 patients with diabetes 41 patient on
oral hypoglycemic agent and 19 patient on insulin at the time of the
study. These patients included 44 male (73.3%) and 16 female (26.7%)
with mean age 56.48 ± 7.8 years. All patients were subjected to stress
thallium at the end of follow-up period (24 month) or at the occurrence
of the cardiac events. Follow-upHbA1c were performed before stenting
and every 6 month till the end of follow-up period. In the study, 30 non-
diabetic patients, who underwent stenting, were enrolled as control.
Results: Regarding the duration of diabetes mellitus (in years),
patients who had cardiac events had longer duration of DM than
who did not (12.83 ± 6.8, 8.17 ± 3.3 yrs with p-value = 0.002).
LDL level was lower in the patients who had no cardiac events than
who did (108 ± 2.15 mg/dl, 123.67 ± 22.5 mg/dl with p-
value = 0.01). While patients who had cardiac events were on shorter
duration of clopidogrel than those who did not (9.7 ± 6.8 month,
16.4 ± 7.0 month with p-value 6 0.01).
Regarding the HbA1c levels, HbA1c in the patients with cardiac
events was P7% while in the none cardiac event patients was 67%
with p-value < 0.01. Also, HBA1c during stenting was higher than
HBA1c during follow-up in the whole diabetic group (9.12 ± 1.67%,
7.45 ± 2.0% with p-value <0.01.
Abstracts / The Egyptian Heart Journal 66 (2014) 1–35 7
